| Insurance Industry | Financials Sector | Mr. Philip Daffas B.Sc., Dip EENG, GAICD, M.B.A. CEO | CNSX Exchange | - ISIN |
| Australia Country | - Employees | - Last Dividend | 8 Jan 2020 Last Split | - IPO Date |
PainChek Limited is an innovative company based in Sydney, Australia, specializing in the development and commercialization of mobile medical device applications aimed at providing comprehensive pain assessment solutions. The company primarily operates in Australia, the United Kingdom, and other international markets. Initially known as ePAT Technologies Ltd, the organization rebranded to PainChek Limited in January 2018. PainChek Limited's mission is to enhance the quality of care for individuals unable to communicate their pain effectively, including those with dementia, pre-verbal infants, and patients in various care sectors such as aged care, disability, home care, hospitals, and the infant sector.
PainChek's offerings focus on leveraging technology to assess and manage pain in individuals who cannot verbally communicate their pain levels. The company's flagship product and services include:
- Patients suffering from dementia: For individuals with dementia who may have difficulty expressing their pain verbally, PainChek offers a non-verbal solution to assess their pain levels accurately.
- Pre-verbal infants: Infants who are not yet able to speak can also benefit from PainChek's technology, ensuring their pain is recognized and managed appropriately.
The application is designed to support various sectors including aged care facilities, disability services, home care providers, hospitals, and infant care settings, making it a versatile tool in improving patient care and pain management strategies.